Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant Investment Progress Announcement

30 Apr 2014 17:03

RNS Number : 9752F
J.P. Morgan Private Equity Ltd
30 April 2014
 

 

SIGNIFICANT INVESTMENT PROGRESS TO DATE

· Invested approximatley $50 million in 4 Companies Since December

· Represents ONE-THIRD OF $150 MILLION of the year-end 2015 Target investment amount

 

GUERNSEY, 30 APRIL 2014

 

In January 2014 JPEL announced that it would seek to invest $150 million through December 2015 in secondary direct deals or concentrated private equity LP positions.

 

JPEL is pleased to announce that with the completion of its fourth investment, it has deployed approximately $50 million of its $150 million investment target. Due to strong distribution flows, JPEL has been able to fund all investments without increasing borrowings under its flexible credit facility.

 

The four investments include:

· In December, JPEL invested approximately $14 million in a US-based tax advisory services firm whose primary business is to provide high-value consulting services relating to government-sponsored tax incentives.

· In February, JPEL invested approximately $14 million in Datamars SA, a leading supplier of animal identification systems (including pet and livestock) and textile identification systems.

· Also in February, JPEL invested approximately $7 million in Placid Holdings, a holding company with an investment in a leading branded Asian handset distributor, with a leading market position in smart phones and feature phones in India.

· In April, JPEL participated in a syndicate of global investors led by Arle Capital to acquire Innovia Group from the Candover 2001 Fund. JPEL invested approximately $14 million in Innovia, an international manufacturer of high quality, speciality films for its key markets of labels, overwrap, packaging and polymer banknote substrate.

 

Each of the four investments share common attributes that JPEL seeks:

· Attractive entry value: On aggregated basis, entry value for the four companies was approximately 6.7x LTM EBITDA and 5.6x 2014P EBITDA

· Manageable leverage: On a weighted average basis, debt at time of investment was approximately 1.8x 2013 LTM EBITDA. 2 of the 4 companies have net cash positions

· High margins: Weighted average LTM EBITDA margins of approximately 25%

· Market leadership: Each of the four companies is a market leader (top 1-3 player) in their respective business segments

· Potential shorter duration: All four companies are existing, mature private equity investments with the potential to be exited in the next 2 to 4 years

· Visible EBITDA growth: Each company projects significant EBITDA growth in the near or mid-term

 

JPEL currently has a very strong investment pipeline and is engaged in due diligence on two potential transactions that could be completed over the next two to three months. Should these investments close, JPEL will have deployed approximately half of its $150 million investment target.

 

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Greg Getschow

+1 212 648 1150

Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPZZ, JPSZ). The Company's capital structure consists of three classes of shares: US$ Equity Shares and two classes of Zero Dividend Preference Shares due 2015 and 2017, respectively.

 

On 15 January 2014, JPEL announced a strategic update, which included plans to maximize net asset value through greater emphasis on JPEL's existing post-credit crisis investment strategy. As part of this update, JPEL announced that it would cease dividend and capital distributions to US$ Equity Shareholders and continue its post-credit crisis investment strategy and will seek to invest $150 million in secondary direct deals or concentrated private equity LP positions. The Company's goal is to create concentrated portfolio to improve ability to assess risk and to increase transparency on underlying portfolio. At the end of the investment period in December 2015, JPEL expects that its top 30 company positions will comprise the majority of its total net asset value.

 

The Company also announced a proposal for the creation of Redeemable Realisation Share Class ("RRS") whereby US$ Equity shareholders would be offered the option to transfer their US$ Equity shares for RRS Shares which will entitle holders to all cash realisations from the Company's investment portfolio in proportion to their aggregate holding within the equity of the Company. This proposal requires shareholder approval and would take effect in 24 months, after the 2015 ZDP Shares are retired.

 

On 15 January 2014, institutional investors purchased 84 million US$ Equity Shares through market purchases at $0.80 per share, an 8.3% premium to the 14 January 2014 share price.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURRNRSOASOAR
Date   Source Headline
10th Jun 20167:00 amRNSNet Asset Value(s)
26th May 20162:00 pmRNSNet Asset Value(s)
10th May 20165:00 pmRNSNet Asset Value(s)
22nd Apr 201612:00 pmRNSStrategic Update
15th Apr 20167:00 amRNSNet Asset Value(s)
1st Apr 20163:15 pmRNSHolding(s) in Company
29th Mar 20167:00 amRNSHalf Yearly Report
11th Mar 20166:21 pmRNSChange of Name
11th Mar 20163:03 pmRNSFortress Transaction and Realisation Share Class
10th Mar 20166:28 pmRNSNet Asset Value and Report for 19 February 2016
26th Feb 201610:00 amRNSEGM Statement
23rd Feb 20167:00 amRNSNet Asset Value(s)
18th Feb 20169:16 amRNSNet Asset Value(s)
5th Feb 20167:00 amRNSNotice of EGM
29th Jan 20167:00 amRNSNet Asset Value(s)
28th Jan 201611:02 amRNSHolding(s) in Company
28th Jan 201611:01 amRNSHolding(s) in Company
27th Jan 201610:00 amRNSNotice to Shareholders - Total Voting Rights
7th Jan 20167:00 amRNSNet Asset Value(s)
8th Dec 20157:00 amRNSFortress Transaction Update
26th Nov 20157:00 amRNSNet Asset Value(s)
16th Nov 201511:00 amRNSRetirement of 2015 ZDP Shares
30th Oct 20157:00 amRNSNet Asset Value(s)
27th Oct 20157:00 amRNSAnnual Financial Report
27th Oct 20157:00 amRNSNotice to Shareholders - Potential Transaction
19th Oct 20157:00 amRNSStatement re Retirement of 2015 ZDP Shares
14th Oct 20155:04 pmRNSHolding(s) in Company
23rd Sep 201511:10 amRNSNet Asset Value(s)
24th Aug 201512:24 pmRNSHolding(s) in Company
20th Aug 20157:00 amRNSNet Asset Value(s)
30th Jul 20159:48 amRNSResult of AGM
16th Jul 20157:00 amRNSNet Asset Value(s)
13th Jul 20154:53 pmRNSAGM Circular
6th Jul 20155:42 pmRNSHolding(s) in Company
1st Jul 20157:00 amRNSNMPI Announcement
30th Jun 20157:00 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSNet Asset Value(s)
12th May 20157:01 amRNSNet Asset Value(s)
9th Apr 20157:00 amRNSNet Asset Value(s)
16th Mar 20157:00 amRNSNet Asset Value(s)
24th Feb 20152:03 pmRNSDirector's Share Purchase
20th Feb 20157:15 amRNSHalf Yearly Report
20th Feb 20157:00 amRNSDirectorate Change
18th Feb 20157:00 amRNSNet Asset Value(s)
29th Jan 20157:00 amRNSNet Asset Value(s)
2nd Jan 201511:12 amRNSHolding(s) in Company
30th Dec 20144:42 pmRNSNet Asset Value(s)
18th Dec 20143:05 pmRNSDirector Declaration
20th Nov 20147:00 amRNSNet Asset Value(s)
18th Nov 20145:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.